Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China

References

• Lontchi-Yimagou E, Nguewa JL, Assah F, et al. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med. 2017;34(3):426–431. doi:10.1111/dme.13264
   PubMed Web of Science ®Google Scholar
• Balasubramanyam A. Syndromes of ketosis-prone diabetes. Trans Am Clin Climatol Assoc. 2019;130:145–155.
   PubMedGoogle Scholar
• Seok H, Jung CH, Kim SW, et al. Clinical characteristics and insulin Independence of Koreans with new-onset type 2 diabetes presenting with diabetic ketoacidosis. Diabetes Metab Res Rev. 2013;29(6):507–513. doi:10.1002/dmrr.2421
   PubMed Web of Science ®Google Scholar
• Elkituni A, Elshwekh H, Bendala NM, et al. Profile of diabetic ketoacidosis at the national diabetes and endocrine center in Tripoli, Libya, 2015. Diabetes Metab Syndr. 2021;15(3):771–775. doi:10.1016/j.dsx.2021.03.014
   PubMed Web of Science ®Google Scholar
• Mekonnen GA, Gelaye KA, Gebreyohannes EA, et al. Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hospital-based study. PLoS One. 2022;17(4):0264626. doi:10.1371/journal.pone.0264626
   Web of Science ®Google Scholar
• Xie XJ, Hu Y, Cheng C, et al. Should diabetic ketosis without acidosis be included in ketosis-prone type 2 diabetes mellitus? Diabetes Metab Res Rev. 2014;30(1):54–59. doi:10.1002/dmrr.2448
   PubMed Web of Science ®Google Scholar
• Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004;53(3):645–653. doi:10.2337/diabetes.53.3.645
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Casals MM, Gebhart SP, et al. Diabetic ketoacidosis in obese African-Americans. Diabetes. 1995;44(7):790–795. doi:10.2337/diab.44.7.790
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006;144(5):350–357. doi:10.7326/0003-4819-144-5-200603070-00011
   PubMed Web of Science ®Google Scholar
• Aizawa T, Katakura M, Taguchi N, et al. Ketoacidosis-onset noninsulin dependent diabetes in Japanese subjects. Am J Med Sci. 1995;310(5):198–201. doi:10.1097/00000441-199511000-00004
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Cui W, et al. The clinical and metabolic characteristics of young-onset ketosis-prone type 2 diabetes in China. Endocr Pract. 2015;21(12):1364–1371. doi:10.4158/EP15778
   PubMed Web of Science ®Google Scholar
• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;28(369). doi:10.1136/bmj.m997
   Google Scholar
• Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–1379. doi:10.1016/s0895-4356(96)00236-3
   PubMed Web of Science ®Google Scholar
• Pi L, Halabi S. Combined performance of screening and variable selection methods in ultra-high dimensional data in predicting time-to-event outcomes. Diagn Progn Res. 2018;2(21):018–0043. doi:10.1186/s41512-018-0043-4
   PubMedGoogle Scholar
• Wang JW, Wang AP, Chen MY, et al. Prevalence and clinical characteristics of hypertension and metabolic syndrome in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. Diabetol Metab Syndr. 2019;11(31):019–0426. doi:10.1186/s13098-019-0426-x
   PubMedGoogle Scholar
• Gupta RD, Ramachandran R, Gangadhara P, et al. Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A-β+ Ketosis-Prone Diabetes (KPD): the first identified cohort amongst Asian Indians. J Diabetes Complications. 2017;31(9):1401–1407. doi:10.1016/j.jdiacomp.2017.06.008
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang M, Liu Z, et al. Heterogeneous clinical features of ketosis-prone type 2 diabetes mellitus patients: gender, age, loss of weight and HbA1c. Minerva Endocrinol. 2019;44(4):351–356. doi:10.23736/S0391-1977.18.02925-5
   PubMed Web of Science ®Google Scholar
• Xiong X, Wei L, Xiao Y, et al. Effects of family history of diabetes on pancreatic β-cell function and diabetic ketoacidosis in newly diagnosed patients with type 2 diabetes: a cross-sectional study in China. BMJ Open. 2021;11(1):2020–041072. doi:10.1136/bmjopen-2020-041072
   Web of Science ®Google Scholar
• Al Hayek AA, Robert AA, Al-Shaikh R, et al. Factors associated with the presence of diabetic ketoacidosis: a retrospective analysis of patients with type 1 diabetes in Saudi Arabia. Diabetes Metab Syndr. 2020;14(6):2117–2122. doi:10.1016/j.dsx.2020.11.002
   PubMed Web of Science ®Google Scholar
• Ye S, Ran H, Zhang H, et al. Elevated serum triglycerides are associated with ketosis-prone type 2 diabetes in young individuals. Diabetes Metab Syndr Obes. 2021;14:497–504. doi:10.2147/DMSO.S296085
   PubMed Web of Science ®Google Scholar
• Du S, Zhang H, Wu H, et al. Prevalence and gender differences of metabolic syndrome in young ketosis-prone type 2 diabetic individuals: a retrospective study. Diabetes Metab Syndr Obes. 2020;13:2719–2727. doi:10.2147/DMSO.S252492
   PubMed Web of Science ®Google Scholar
• Bradford AL, Crider CC, Xu X, et al. Predictors of recurrent hospital admission for patients presenting with diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Med Res. 2017;9(1):35–39. doi:10.14740/jocmr2792w
   PubMedGoogle Scholar
• Zhu B, Bu L, Zhang M, et al. HbA1c as a screening tool for ketosis in patients with type 2 diabetes mellitus. Sci Rep. 2016;6(39687). doi:10.1038/srep39687
   Google Scholar
• Gao W, Qiao Q, Tuomilehto J. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events. Clin Lab. 2004;50(9–10):609–615.
   PubMedGoogle Scholar
• Ceriello A, Genovese S. Atherogenicity of postprandial hyperglycemia and lipotoxicity. Rev Endocr Metab Disord. 2016;17(1):111–116. doi:10.1007/s11154-016-9341-8
   PubMed Web of Science ®Google Scholar
• Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 2021;171(2):179–189. doi:10.1007/s10517-021-05191-7
   PubMed Web of Science ®Google Scholar
• Cernea S, Dobreanu M. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem Med. 2013;23(3):266–280. doi:10.11613/bm.2013.033
   PubMed Web of Science ®Google Scholar
• Waddankeri SS, Swaraj Waddankeri M, Gurushantappa Mangshetty B. Clinical and biochemical characteristics and treatment outcomes of ketosis-prone diabetes: the remission prone diabetes. Int J Endocrinol Metab. 2021;19(2):106799. doi:10.5812/ijem.106799
   Web of Science ®Google Scholar
• Gupta RD, Atri A, Mondal S, et al. Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-β+ KPD (ketosis-prone diabetes): a prospective study from Eastern India. J Diabetes Complications. 2022;36(3):108100. doi:10.1016/j.jdiacomp.2021.108100
   PubMed Web of Science ®Google Scholar